Acesion Pharma receives 5M DKK from Innovation Fund Denmark to support human Proof-of-Concept study
Acesion Pharma (“Acesion” or the Company), a Danish biotech company developing novel treatments for atrial fibrillation (AF), the most...
top of page
- Nov 5, 2018
- 2 min
Acesion Pharma Announces Positive Results for Novel Drug Targeting Atrial Fibrillation
Acesion Pharma (“Acesion” or the Company), a Danish biotech company developing novel treatments for atrial fibrillation (AF), the most...
157 views
- Mar 12, 2018
- 2 min
Acesion Pharma Commences Phase 1 Study in Atrial Fibrillation
Acesion Pharma (“Acesion” or the Company), a Danish biotech company developing novel treatments for atrial fibrillation (AF), the most...
45 views
LATEST NEWS
bottom of page